Saqlain Suleman has joined the TestAVec team as Principal Scientific Officer. He will be working to develop and lead projects in...

Bluebird Bio has halted a phase 3 gene therapy clinical trial against cerebral adrenoleukodystrophy. This trial use lentiviral vectors...

TestaAVec will be attending the ESGCT Virtual Congress, this October. The Congress will be joint with other European gene therapy...

Brunel University Spin Out Testavec Ltd will be presenting its novel vector safety assessment platform at the Oxford Biosciences...

Testavec signs cooperation agreement with Genewerk GMBH one the world’s leading companies operating in the field of vector efficacy and...